A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.

Trial Details

NCT ID
NCT06915246
Phase
PHASE2
Sponsor
VIVUS LLC
Status
RECRUITING
Cancer Type
Non-Hodgkin Lymphoma Lymphoma
Interventions
  • VI-0609
  • BiCNU
Locations (sample)
  • Goodyear, Arizona, United States|33.43532,-112.35821
  • Duarte, California, United States|34.13945,-117.97729
  • Newnan, Georgia, United States|33.38067,-84.79966
  • Zion, Illinois, United States|42.44613,-87.83285

Key Eligibility Criteria

  • Male and female adults ≥ 18 years of age with a life expectancy ≥ 6 months;
  • Karnofsky performance status ≥ 70%;
  • Histologically confirmed Hodgkin lymphoma or Non-Hodgkin lymphoma;
  • Candidate for AHCT consolidation therapy as assessed by their treating physician;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Non-Hodgkin Lymphoma Lymphoma Trials on Trialify →